Incidence of hypoglycaemia in patients with type-2 diabetes taking multiple glucose lowering therapies during Ramadan: the PROFAST Ramadan Study.

Tarik ElhaddZeinab DabbousMohammed BashirAbdulnasir ElzoukiWissam GhadbanKhaled BaagarSilas BenjaminMohamed HassanienAbazar A M SaeedKhaled DukhanRayaz A MalikAbdul-Badie Abou-Samranull null

Published in: Journal of diabetes and metabolic disorders (2018)

Despite the tailored advice, there is a high incidence of hypoglycemia in people with T2DM taking multiple glucose lowering therapies whilst fasting during Ramadan. Guidelines should address the increased complexity in anti-diabetic medications in patients who fast during Ramadan. Healthcare providers should individualize the modifications in anti-diabetic medications during Ramadan.

Keyphrases

type diabetes
healthcare
blood glucose
risk factors
metabolic syndrome
adipose tissue
smoking cessation
health information
weight loss